BD Launches AI-Driven Research Cloud 7.0 to Enhance Scientific Collaboration and Efficiency
- Becton Dickinson launches BD® Research Cloud 7.0, enhancing scientific collaboration in immunology and cancer research.
- The BD Horizon™ Panel Maker uses AI to optimize experimental panel design, improving data reliability and research efficiency.
- BD's investment in cloud technology aims to enhance laboratory operations and support scientists globally with advanced tools.
BD Launches AI-Driven Research Cloud 7.0 to Transform Scientific Collaboration
Becton, Dickinson and Company (BD) announces the global commercial release of BD® Research Cloud 7.0, a significant advancement in the realm of scientific research, particularly targeting immunology and cancer studies. This cutting-edge platform introduces the BD Horizon™ Panel Maker, an artificial intelligence (AI) tool designed to enhance the quality and efficiency of research outcomes. By streamlining workflows and improving collaboration among scientists, BD aims to address the challenges faced in laboratory settings, particularly those related to poorly designed experimental panels that can compromise data integrity and resource allocation.
The BD Horizon™ Panel Maker employs a sophisticated AI algorithm that quickly generates optimized panel recommendations, allowing researchers to develop experimental panels based on custom inputs or validated databases in mere seconds. This innovation tackles a prevalent issue in scientific research: the occurrence of unreliable data stemming from inadequately designed panels. By automating the recommendation process and incorporating integrated visualization tools like comparison tables and complexity scores, the BD Horizon™ Panel Maker empowers scientists to make informed decisions about their experiments, ultimately enhancing the reliability of their results.
Steve Conly, the worldwide president of BD Biosciences, emphasizes that the new capabilities introduced with BD® Research Cloud are aimed at expediting the research process while minimizing potential errors. The panel maker not only streamlines panel design but also complements the functionalities of BD's advanced hardware, such as the BD FACSDiscover™ Cell Analyzer and Cell Sorters. This synergy between hardware and software ensures that researchers can maximize their experimental capabilities, reinforcing BD's position as a leader in flow cytometry and life sciences research.
In addition to this innovative tool, BD's commitment to advancing scientific research through technology is evident in its ongoing investment in cloud-based ecosystems that enhance laboratory operations. By facilitating better management of instrument health and reagent procurement, BD continues to support the evolving needs of scientists worldwide.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

